Diaz Ariel, Merino Paola, Manrique Luis Guillermo, Ospina Juan Pablo, Cheng Lihong, Wu Fang, Jeanneret Valerie, Yepes Manuel
Department of Neurology and Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia 30322.
Division of Neuropharmacolgy and Neurologic Diseases, Yerkes National Primate Research Center, Atlanta, Georgia 30329, and.
J Neurosci. 2017 Oct 25;37(43):10310-10322. doi: 10.1523/JNEUROSCI.1630-17.2017. Epub 2017 Sep 20.
Urokinase-type plasminogen activator (uPA) is a serine proteinase that, upon binding to its receptor (uPAR), catalyzes the conversion of plasminogen into plasmin on the cell surface. Our previous studies indicate that uPA and uPAR expression increase in the ischemic brain during the recovery phase from an acute ischemic injury and that uPA binding to uPAR promotes neurological recovery after an acute ischemic stroke. Here, we used male mice genetically deficient on either uPA (uPA) or uPAR (uPAR) or with a four-amino acid substitution into the growth factor domain of uPA that abrogates its binding to uPAR () to investigate the mechanism whereby uPA promotes neurorepair in the ischemic brain. We found that neurons release uPA and astrocytes recruit uPAR to their plasma membrane during the recovery phase from a hypoxic injury and that binding of neuronal uPA to astrocytic uPAR induces astrocytic activation by a mechanism that does not require plasmin generation, but instead is mediated by extracellular signal-regulated kinase 1/2 (ERK1/2)-regulated phosphorylation of the signal transducer and activator of transcription 3 (STAT3). We report that uPA/uPAR binding is necessary and sufficient to induce astrocytic activation in the ischemic brain and that astrocytes activated by neuronal uPA promote synaptic recovery in neurons that have suffered an acute hypoxic injury via a mechanism mediated by astrocytic thrombospondin-1 (TSP1) and synaptic low-density lipoprotein receptor-related protein-1 (LRP1). In summary, we show that uPA/uPAR-induced astrocytic activation mediates a cross talk between astrocytes and injured neurons that promotes synaptic recovery in the ischemic brain. To date, there is no therapeutic strategy to promote synaptic recovery in the injured brain. Here, we show that neurons release urokinase-type plasminogen activator (uPA) and astrocytes recruit the uPA receptor (uPAR) to their plasma membrane during the recovery phase from a hypoxic injury. We found that binding of neuronal uPA to astrocytic uPAR promotes astrocytic activation and that astrocytes activated by uPA-uPAR binding promote synaptic recovery in neurons that have suffered a hypoxic injury by a mechanism that does not require plasmin generation, but instead is mediated by ERK1/2-regulated STAT3 phosphorylation, astrocytic thrombospondin-1 (TSP1) and synaptic low-density lipoprotein receptor-related protein-1 (LRP1). Our work unveils a new biological function for uPA-uPAR as mediator of a neuron-astrocyte cross talk that promotes synaptic recovery in the ischemic brain.
尿激酶型纤溶酶原激活剂(uPA)是一种丝氨酸蛋白酶,它与受体(uPAR)结合后,可在细胞表面催化纤溶酶原转化为纤溶酶。我们之前的研究表明,在急性缺血性损伤恢复阶段,缺血脑中uPA和uPAR的表达会增加,并且uPA与uPAR的结合可促进急性缺血性中风后的神经功能恢复。在此,我们使用了uPA基因缺陷型(uPA -/-)或uPAR基因缺陷型(uPAR -/-)的雄性小鼠,或者uPA生长因子结构域中有四个氨基酸被替换从而消除其与uPAR结合能力的小鼠(uPA -/Y),来研究uPA促进缺血脑神经元修复的机制。我们发现,在缺氧损伤恢复阶段,神经元会释放uPA,星形胶质细胞会将uPAR募集到其质膜上,并且神经元uPA与星形胶质细胞uPAR的结合通过一种不依赖纤溶酶生成的机制诱导星形胶质细胞活化,而是由细胞外信号调节激酶1/2(ERK1/2)调节的信号转导和转录激活因子3(STAT3)磷酸化介导。我们报告称,uPA/uPAR结合对于诱导缺血脑星形胶质细胞活化是必要且充分的,并且由神经元uPA激活的星形胶质细胞通过由星形胶质细胞凝血酶敏感蛋白-1(TSP1)和突触低密度脂蛋白受体相关蛋白-1(LRP1)介导的机制促进遭受急性缺氧损伤的神经元的突触恢复。总之,我们表明uPA/uPAR诱导的星形胶质细胞活化介导了星形胶质细胞与受损神经元之间的相互作用,从而促进缺血脑的突触恢复。迄今为止,尚无促进受损脑突触恢复的治疗策略。在此,我们表明在缺氧损伤恢复阶段,神经元会释放尿激酶型纤溶酶原激活剂(uPA),星形胶质细胞会将uPA受体(uPAR)募集到其质膜上。我们发现神经元uPA与星形胶质细胞uPAR的结合促进星形胶质细胞活化,并且由uPA - uPAR结合激活的星形胶质细胞通过一种不依赖纤溶酶生成的机制促进遭受缺氧损伤的神经元的突触恢复,而是由ERK1/2调节的STAT3磷酸化、星形胶质细胞凝血酶敏感蛋白-1(TSP1)和突触低密度脂蛋白受体相关蛋白-1(LRP1)介导。我们的工作揭示了uPA - uPAR作为神经元 - 星形胶质细胞相互作用的介质的新生物学功能,该相互作用促进缺血脑的突触恢复。